methylprednisolone has been researched along with Central Nervous System Lupus in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 16 (51.61) | 29.6817 |
| 2010's | 12 (38.71) | 24.3611 |
| 2020's | 3 (9.68) | 2.80 |
| Authors | Studies |
|---|---|
| Darby, DG; Fong, C; Wong, AK | 1 |
| Maikap, D; Mv, P; Padhan, P | 1 |
| Brites, L; Luis, M; Rodrigues, M; Santiago, M | 1 |
| Ding, W; Hu, B; Peng, Y; Qi, X; Tang, X; Wu, P; Zhang, M; Zhou, Y | 1 |
| Abe, S; Asashima, H; Hagiwara, S; Hirota, T; Honda, F; Kondo, Y; Matsumoto, I; Ohyama, A; Sumida, T; Takahashi, H; Toko, H; Tsuboi, H; Umeda, N; Yokosawa, M | 1 |
| Fu, B; Lei, H; Wang, J; Zhang, J; Zhao, Y; Zhu, G | 1 |
| Chang, HW; Kim, JM; Kim, SH; Son, CN | 1 |
| Atisha-Fregoso, Y; Fragoso-Loyo, H; Llorente, L; Quintanilla-González, L | 1 |
| Hähnel, S; Hug, A; Rizos, T; Siegelin, M; Storch-Hagenlocher, B | 1 |
| Chen, YT; Lin, H; Liu, Y; Tan, CY; Tang, HH; Wang, JG | 1 |
| Chattopadhyay, P; Dhua, D; Philips, C | 1 |
| Hoshika, A; Kawashima, H; Sato, S; Yoshio, T | 1 |
| Arellanes-Garcia, L; Cornejo-Ballesteros, H; Hernandez-Da Mota, SE; Melgoza-del-Angel, C; Recillas-Gispert, C; Sanchez-Gonzalez, R; Teran-Estrada, L | 1 |
| Chilov, M; Damato, E; Dick, A; Harper, S; Lee, R; Singh, A | 1 |
| Harashima, C; Harashima, S; Horiuchi, T; Kashiwagi, Y; Matsubara, F | 1 |
| Correia, T; Fernandes, VS; Ferraria, N; Gonçalves, E; Rocha, S | 1 |
| Fabiani, G; Germiniani, FM; Sá, DS; Teive, HA; Werneck, LC | 1 |
| Cohen, B; DeAmicis, T; Mofid, MZ; Nousari, HC | 1 |
| Chacón, J; García-Moreno, JM | 1 |
| Butani, L; Makker, SP | 1 |
| Ho, ST; Huang, WS; Kao, CH; Liu, FY; Wang, JJ; Yen, RF | 1 |
| Chang, CP; Chen, JJ; Huang, WS; Kao, CH; Sun, SS; Wang, JJ | 1 |
| Al-Mayouf, SM; Muzaffer, MA; Olfat, MO | 1 |
| Alocer-Varela, J; Ariza-Andraca, R; Barile-Fabris, L; Clark, P; Fraga-Mouret, A; Fuentes de la Mata, J; Jara, LJ; Miranda-Limón, JM; Olguín-Ortega, L; Vargas, F | 1 |
| Akiyama, O; Hagiwara, K; Matsuno, H; Sato, T; Takeda, K; Unno, S | 1 |
| Asanuma, Y; Moriguchi, M; Murayama, J; Nishida, J; Tsuda, T | 1 |
| Baba, A; Eto, T; Fujimoto, S; Fukuda, A; Hara, S; Iwatsubo, S; Nishiura, R; Sato, Y; Tatsumoto, M; Yamada, K | 1 |
| Everett, CM; Graves, TD; Hanna, MG; Isenberg, DA; Jäger, HR; Lad, S; Thom, M | 1 |
| Duprez, T; Houssiau, FA; Nzeusseu, A; Peeters, A | 1 |
| Baskin, E; Cila, A; Eren, M; Ozen, S | 1 |
| Foley-Nolan, D; Gibbs, AN; Moroney, J; O'Connell, PG | 1 |
1 review(s) available for methylprednisolone and Central Nervous System Lupus
| Article | Year |
|---|---|
Juvenile parkinsonism as a manifestation of systemic lupus erythematosus: case report and review of the literature.
Topics: Adult; Diagnosis, Differential; Drug Therapy, Combination; Humans; Levodopa; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Male; Methylprednisolone; Neurologic Examination; Parkinsonian Disorders; Prednisolone; Recurrence | 2002 |
1 trial(s) available for methylprednisolone and Central Nervous System Lupus
| Article | Year |
|---|---|
Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus.
Topics: Acute Disease; Adolescent; Adult; Antirheumatic Agents; Cyclophosphamide; Drug Administration Schedule; Follow-Up Studies; Humans; Immunosuppressive Agents; Lupus Vasculitis, Central Nervous System; Methylprednisolone; Middle Aged; Severity of Illness Index; Treatment Outcome | 2005 |
29 other study(ies) available for methylprednisolone and Central Nervous System Lupus
| Article | Year |
|---|---|
Acute cortical blindness caused by neuropsychiatric systemic lupus erythematosus.
Topics: Blindness, Cortical; Cyclophosphamide; Humans; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Male; Methylprednisolone; Vision Disorders | 2023 |
Parkinsonism as the presenting manifestation of lupus: A case-based review.
Topics: Female; Humans; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Methylprednisolone; Middle Aged; Parkinsonian Disorders | 2023 |
New onset weakness in the face and arm.
Topics: Adult; Arm; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Methylprednisolone; Neuroimaging; Neuroprotective Agents; Paresis; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
A case of neuropsychiatric lupus Erythematosus characterized by the Owl's eye sign: a case report.
Topics: Brain; Female; Headache; Humans; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Magnetic Resonance Imaging; Medulla Oblongata; Methylprednisolone; White Matter; Young Adult | 2017 |
Intractable Hemophagocytic Syndrome Associated with Systemic Lupus Erythematosus Resistant to Corticosteroids and Intravenous Cyclophosphamide That Was Successfully Treated with Cyclosporine A.
Topics: Administration, Intravenous; Adrenal Cortex Hormones; Cyclophosphamide; Cyclosporine; Dermatologic Agents; Humans; Immunosuppressive Agents; Lupus Vasculitis, Central Nervous System; Lymphohistiocytosis, Hemophagocytic; Male; Methylprednisolone; Young Adult | 2018 |
Impact analysis of autoantibody level and NR2 antibody level in neuropsychiatric SLE treated by methylprednisolone combined with MTX and DXM intrathecal injection.
Topics: Adult; Autoantibodies; Dextromethorphan; Drug Interactions; Female; Humans; Injections, Spinal; Lupus Vasculitis, Central Nervous System; Methotrexate; Methylprednisolone; Receptors, N-Methyl-D-Aspartate; Treatment Outcome | 2014 |
Simultaneous presentation of acute disseminated encephalomyelitis (ADEM) and systemic lupus erythematosus (SLE) after enteroviral infection: can ADEM present as the first manifestation of SLE?
Topics: Adolescent; Anti-Inflammatory Agents; Antibodies, Antinuclear; Biopsy; Cyclophosphamide; Diagnosis, Differential; Encephalomyelitis, Acute Disseminated; Enterovirus Infections; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Magnetic Resonance Imaging; Methylprednisolone; Pulse Therapy, Drug | 2015 |
Myelitis in systemic lupus erythematosus: clinical characteristics and effect in accrual damage. A single-center experience.
Topics: Adult; Brain; Cerebrospinal Fluid; Cyclophosphamide; Female; Hospitalization; Humans; Lupus Vasculitis, Central Nervous System; Magnetic Resonance Imaging; Male; Methylprednisolone; Mexico; Myelitis, Transverse; Neuroprotective Agents; Retrospective Studies; Severity of Illness Index; Young Adult | 2017 |
Fulminant onset of cerebral immunocomplex vasculitis as first manifestation of neuropsychiatric systemic lupus erythematosus (NPSLE).
Topics: Biopsy; Brain; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Vasculitis, Central Nervous System; Methylprednisolone; Middle Aged; Prognosis | 2009 |
Diffuse lupus encephalopathy in a case of rhupus syndrome.
Topics: Adult; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Asian People; Brain; Encephalitis; Female; Humans; Joints; Lupus Vasculitis, Central Nervous System; Magnetic Resonance Imaging; Methylprednisolone; Nerve Fibers, Myelinated; Seizures; Treatment Outcome | 2010 |
Reversible diffuse neurological deficits in systemic lupus erythematosus: report of a case.
Topics: Brain; Female; Humans; Infusions, Intravenous; Leukoencephalopathies; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Magnetic Resonance Imaging; Methylprednisolone; Nervous System Diseases; Young Adult | 2011 |
Clinical analysis of anti-NR2 glutamate receptor antibodies and interleukin-6 with neuropsychiatric systemic lupus erythematosus.
Topics: Adolescent; Anticoagulants; Autoantibodies; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Interleukin-6; Lupus Vasculitis, Central Nervous System; Magnetic Resonance Imaging; Methylprednisolone; Receptors, N-Methyl-D-Aspartate | 2011 |
Lupus relapse presented as frosted branch retinal angiitis: case report.
Topics: Adolescent; Azathioprine; Female; Humans; Immunosuppressive Agents; Lupus Vasculitis, Central Nervous System; Methylprednisolone; Prednisone; Pregnenediones; Recurrence; Retinal Vasculitis; Treatment Outcome | 2011 |
Plasma exchange and rituximab in the management of acute occlusive retinal vasculopathy secondary to systemic lupus erythematosus.
Topics: Acute Disease; Adult; Antibodies, Monoclonal, Murine-Derived; Female; Fluorescein Angiography; Humans; Immunosuppressive Agents; Lupus Vasculitis, Central Nervous System; Methylprednisolone; Mycophenolic Acid; Neuroprotective Agents; Plasma Exchange; Prednisolone; Retinal Artery Occlusion; Retinal Vasculitis; Rituximab; Treatment Outcome; Visual Acuity | 2011 |
Marchiafava-Bignami disease-like lesions due to central nervous system lupus.
Topics: Administration, Oral; Adult; Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents; Antibodies, Antinuclear; Corpus Callosum; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Follow-Up Studies; Humans; Lupus Vasculitis, Central Nervous System; Marchiafava-Bignami Disease; Methylprednisolone; Necrosis; Prednisolone; Proteinuria; Pulse Therapy, Drug | 2010 |
Juvenile systemic lupus erythematosus with primary neuropsychiatric presentation.
Topics: Anti-Inflammatory Agents; Antibodies, Antinuclear; Ataxia; Azathioprine; Child; Cognition Disorders; Cyclophosphamide; Diagnosis, Differential; Diplopia; Encephalitis; Female; Headache; Humans; Immunosuppressive Agents; Lupus Vasculitis, Central Nervous System; Mental Disorders; Methylprednisolone; Vomiting | 2013 |
Reversible parkinsonian syndrome in systemic and brain vasculitis.
Topics: Adult; Anti-Inflammatory Agents; Electroencephalography; Female; Humans; Kidney Failure, Chronic; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Magnetic Resonance Imaging; Methylprednisolone; Parkinsonian Disorders; Pulse Therapy, Drug; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Vasculitis | 2002 |
Hypocomplementemic urticarial vasculitis: report of a 12-year-old girl with systemic lupus erythematosus.
Topics: Acute Disease; Anti-Inflammatory Agents; Child; Complement System Proteins; Female; Humans; Lupus Vasculitis, Central Nervous System; Methylprednisolone; Pancreatitis; Urticaria | 2002 |
Life-threatening extrarenal lupus in children despite improvement in serologic findings.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Female; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Lupus Vasculitis, Central Nervous System; Methylprednisolone; Myocarditis; Treatment Outcome | 2003 |
Usefulness of Tc-99m ECD brain SPECT to evaluate the effects of methylprednisolone pulse therapy in lupus erythematosus with brain involvement: a preliminary report.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Anticardiolipin; Autoantibodies; Brain; Cerebrovascular Circulation; Cysteine; Female; Humans; Lupus Vasculitis, Central Nervous System; Methylprednisolone; Organotechnetium Compounds; Protozoan Proteins; Pulse Therapy, Drug; Radiopharmaceuticals; Ribosomal Proteins; Tomography, Emission-Computed, Single-Photon | 2003 |
Evaluation of the effects of methylprednisolone pulse therapy in patients with systemic lupus erythematosus with brain involvement by Tc-99m HMPAO brain SPECT.
Topics: Adult; Antibodies, Anticardiolipin; Brain; Cerebrovascular Circulation; Female; Glucocorticoids; Humans; Lupus Vasculitis, Central Nervous System; Methylprednisolone; Organotechnetium Compounds; Oximes; Pulse Therapy, Drug; Radiopharmaceuticals; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 2004 |
Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosus.
Topics: Adolescent; Cerebrovascular Disorders; Child; Child, Preschool; Disease-Free Survival; Electroencephalography; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Lupus Vasculitis, Central Nervous System; Magnetic Resonance Imaging; Male; Methylprednisolone; Nervous System Diseases; Prednisone; Treatment Outcome | 2004 |
Magnetic resonance imaging of optic neuritis in a patient with systemic lupus erythematosus.
Topics: Adult; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Magnetic Resonance Imaging; Methylprednisolone; Optic Neuritis; Pulse Therapy, Drug; Treatment Outcome | 2006 |
[Appearance of central nervous system lupus during corticosteroid therapy and warfarinization in a patient with pure red cell aplasia and antiphospholipid syndrome].
Topics: Antiphospholipid Syndrome; Cyclophosphamide; Female; Humans; Lupus Vasculitis, Central Nervous System; Methylprednisolone; Middle Aged; Pulse Therapy, Drug; Red-Cell Aplasia, Pure; Warfarin | 2006 |
[Elderly male patient with central nervous system lupus undergoing hemodialysis].
Topics: Aged; Consciousness Disorders; Humans; Immunosorbent Techniques; Lupus Vasculitis, Central Nervous System; Magnetic Resonance Imaging; Male; Methylprednisolone; Plasma Exchange; Pulse Therapy, Drug; Renal Dialysis; Treatment Outcome | 2006 |
Aggressive CNS lupus vasculitis in the absence of systemic disease activity.
Topics: Anticonvulsants; Autoantibodies; Azathioprine; Brain; Cyclophosphamide; Electroencephalography; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Lupus Vasculitis, Central Nervous System; Magnetic Resonance Imaging; Methylprednisolone; Neuroprotective Agents; Phenytoin; Seizures; Serologic Tests; Treatment Outcome | 2008 |
Selective involvement of the choroid plexus on cerebral magnetic resonance images: a new radiological sign in patients with systemic lupus erythematosus with neurological symptoms.
Topics: Adult; Anti-Inflammatory Agents; Choroid Plexus; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Lupus Vasculitis, Central Nervous System; Magnetic Resonance Imaging; Meningitis; Methylprednisolone; Treatment Outcome | 2001 |
Mannitol treatment in central nervous system lupus.
Topics: Administration, Oral; Allopurinol; Brain Ischemia; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Free Radical Scavengers; Humans; Injections, Intravenous; Lupus Nephritis; Lupus Vasculitis, Central Nervous System; Magnetic Resonance Imaging; Mannitol; Methylprednisolone; Prednisolone; Treatment Outcome | 2001 |
Neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus: a case report.
Topics: Anti-Inflammatory Agents; Azathioprine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Vasculitis, Central Nervous System; Male; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Plasmapheresis; Prednisolone; Treatment Outcome | 2002 |